A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression

References

• Abraha I, Montedori A. 2010. Modified intention to treat reporting in randomised controlled trials: systematic review. Br Med J 340:c2697.
   PubMed Web of Science ®Google Scholar
• Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P. 2006. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry 59:395–400.
   PubMedGoogle Scholar
• Baxter LR, Jr., Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, . 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243–250.
   PubMed Web of Science ®Google Scholar
• Benedict RHB. 1997. Brief Visual Memory Test, Revised. Odessa, FL: Psychological Assessment Resources.
   Google Scholar
• Berman RM, Narasimhan M, Sanacora G, Miano AP, Hoffman RE, Hu XS, . 2000. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 47:332–337.
   PubMed Web of Science ®Google Scholar
• Brakemeier EL, Luborzewski A, Danker-Hopfe H, Kathmann N, Bajbouj M. 2007. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res 41:395–403.
   PubMed Web of Science ®Google Scholar
• Brandt J, Benedict RHB. 2001. Hopkins Verbal Learning Test Revised. Odessa, FL: Psychological Assessment Resources.
   Google Scholar
• Burt T, Lisanby SH, Sackeim HA. 2002. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 5:73–103.
   PubMed Web of Science ®Google Scholar
• Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, . 1997a. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48:1398–1403.
   PubMed Web of Science ®Google Scholar
• Chen R, Gerloff C, Classen J, Wassermann EM, Hallett M, Cohen LG. 1997b. Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters. Electroencephalogr Clin Neurophysiol 105:415–421.
   PubMedGoogle Scholar
• Cohen CI, Amassian VE, Akande B, Maccabee PJ. 2003. The efficacy and safety of bilateral rTMS in medication-resistant depression. J Clin Psychiatry 64:613–614.
   Google Scholar
• Conca A, Di Pauli J, Beraus W, Hausmann A, Peschina W, Schneider H, . 2002. Combining high and low frequencies in rTMS antidepressive treatment: preliminary results. Hum Psychopharmacol 17:353–356.
   PubMedGoogle Scholar
• Daskalakis ZJ, Levinson AJ, Fitzgerald PB. 2008. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry 53:555–566.
   PubMed Web of Science ®Google Scholar
• Dew MA, Whyte EM, Lenze EJ, Houck PR, Mulsant BH, Pollock BG, . 2007. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 164:892–899.
   Google Scholar
• Fava M. 2003. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53:649–659.
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, . 2006. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 163: 1161–1172.
   Google Scholar
• Fitzgerald PB. 2007. Repetitive transcranial magnetic stimulation is not as effective as electroconvulsive therapy for major depression. Evid Based Ment Health 10:78.
   Google Scholar
• Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. 2003. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 60:1002–1008.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, de Castella A, Bradshaw JL, . 2004. Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord 82:71–76.
   Google Scholar
• Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. 2006a. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 163:88–94.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Fountain S, Daskalakis ZJ. 2006b. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 117:2584–2596.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ. 2008. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 29:683–695.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. 1975. Mini-Mental State Practical method for grading cognitive state of patients for clinician. J Psychiatr Res 12:189–198.
   PubMed Web of Science ®Google Scholar
• Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO, . 2006. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol 9:641–654.
   PubMed Web of Science ®Google Scholar
• George MS, Wassermann EM, Williams WA, Steppel J, Pascual-Leone A, Basser P, . 1996. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci 8:172–180.
   PubMed Web of Science ®Google Scholar
• George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, . 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 67:507–516.
   PubMed Web of Science ®Google Scholar
• Gross M, Nakamura L, Pascual-Leone A, Fregni F. 2007. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 116:165–173.
   PubMed Web of Science ®Google Scholar
• Hausmann A, Kemmler G, Walpoth M, Mechtcheriakov S, Kramer-Reinstadler K, Lechner T, . 2004. No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled “add on” trial. J Neurol Neurosurg Psychiatry 75:320–322.
   PubMed Web of Science ®Google Scholar
• Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, . 2009. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 66:509–515.
   PubMed Web of Science ®Google Scholar
• Herwig U, Fallgatter AJ, Hoppner J, Eschweiler GW, Kron M, Hajak G, . 2007. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry 191:441–448.
   PubMed Web of Science ®Google Scholar
• , Holtzheimer PE 3rdRusso J, Avery DH. 2001. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull 35:149–169.
   Google Scholar
• Insel TR. 2006. Beyond efficacy: the STAR*D trial. Am J Psychiatry 163:5–7.
   PubMed Web of Science ®Google Scholar
• Joo JH, Lenze EJ, Mulsant BH, Begley AE, Weber EM, Stack JA, . 2002. Risk factors for falls during treatment of late-life depression. J Clin Psychiatry 63:936–941.
   Google Scholar
• Jorge RE, Moser DJ, Acion L, Robinson RG. 2008. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 65:268–276.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, . 2003. The epidemiology of major depressive disorder: Results From the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 289:3095–3105.
   PubMed Web of Science ®Google Scholar
• Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, . 1999. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 46:1603–1613.
   PubMed Web of Science ®Google Scholar
• Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, . 1999. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 56:315–320.
   PubMed Web of Science ®Google Scholar
• Kozel FA, George MS. 2002. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract 8:270–275.
   PubMedGoogle Scholar
• Krishnan V, Nestler EJ. 2008. The molecular neurobiology of depression. Nature 455:894–902.
   PubMed Web of Science ®Google Scholar
• Kumar A, Bilker W, Jin Z, Udupa J. 2000. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 22:264–274.
   PubMedGoogle Scholar
• Kupfer DJ. 2005. Achieving adequate outcomes in geriatric depression: standardized criteria for remission. J Clin Psychopharmacol 25:S24–28.
   PubMedGoogle Scholar
• Lisanby SH. 2007. Electroconvulsive therapy for depression. New Engl J Med 357:1939–1945.
   PubMed Web of Science ®Google Scholar
• Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA. 2001. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry 49:460–463.
   PubMed Web of Science ®Google Scholar
• Loo CK, Mitchell PB. 2005. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88:255–267.
   PubMed Web of Science ®Google Scholar
• Loo C, Mitchell P, Sachdev P, McDarmont B, Parker G, Gandevia S. 1999. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 156:946–948.
   PubMed Web of Science ®Google Scholar
• Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, . 2003. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychol Med 33:33–40.
   PubMed Web of Science ®Google Scholar
• Manes F, Jorge R, Morcuende M, Yamada T, Paradiso S, Robinson RG. 2001. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr 13:225–231.
   PubMed Web of Science ®Google Scholar
• Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. 2003. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 182:480–491.
   PubMed Web of Science ®Google Scholar
• Matthews CG, Klove H. 1964. Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
   Google Scholar
• McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, . 2006. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medi cation trials for depression: a STAR*D report. Am J Psychiatry 163:1531–141; quiz 1666.
   Google Scholar
• Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, . 2009. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 66:838–847.
   PubMed Web of Science ®Google Scholar
• Mosimann UP, Marre SC, Werlen S, Schmitt W, Hess CW, Fisch HU, . 2002. Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Arch Gen Psychiatry 59: 560 561.
   PubMed Web of Science ®Google Scholar
• Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Muri RM, Berkhoff M, . 2004. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res 126:123–133.
   PubMed Web of Science ®Google Scholar
• Nahas Z, Li X, Kozel FA, Mirzki D, Memon M, Miller K, . 2004. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55 75 years of age: a pilot study. Depress Anxiety 19:249–256.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, . 2006. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 163: 1519 1530; quiz 1665.
   PubMed Web of Science ®Google Scholar
• Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, . 2001. Decreased regional brain metabolism after ect. Am J Psychiatry 158:305–308.
   PubMed Web of Science ®Google Scholar
• O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, . 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62:1208–1216.
   PubMed Web of Science ®Google Scholar
• Papakostas GI. 2008. Tolerability of modern antidepressants. J Clin Psychiatry 69(Suppl E1):8 13.
   Google Scholar
• Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M. 1994. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117:847–858.
   PubMed Web of Science ®Google Scholar
• Pascual-Leone A, Rubio B, Pallardo F, Catala MD. 1996. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 348:233–237.
   PubMed Web of Science ®Google Scholar
• Patten SB, Wang JL, Williams JV, Currie S, Beck CA, Maxwell CJ, . 2006. Descriptive epidemiology of major depression in Canada. Can J Psychiatry 51:84–90.
   PubMed Web of Science ®Google Scholar
• Peleman K, Van Schuerbeek P, Luypaert R, Stadnik T, De Raedt R, De Mey J, . 2010. Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. World J Biol Psychiatry 11:425–430.
   PubMed Web of Science ®Google Scholar
• Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, . 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 17:244–253.
   PubMed Web of Science ®Google Scholar
• Pincus HA, Pettit AR. 2001. The societal costs of chronic major depression. J Clin Psychiatry 62(Suppl 6):5 9.
   PubMed Web of Science ®Google Scholar
• Randolph C, Tierney MC, Mohr E, Chase TN. 1998. The repeatable battery for the assessment of neuropsychological status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol 20:310–319.
   PubMed Web of Science ®Google Scholar
• Reynolds CF 3rd, Frank E, Kupfer DJ, Thase ME, Perel JM, Mazumdar S, . 1996. Treatment outcome in recurrent major depression: a post hoc comparison of elderly (“young old”) and midlife patients. Am J Psychiatry 153:1288–1292.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, . 1994. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79–92.
   PubMedGoogle Scholar
• Rotenberg VS. 2004. The peculiarity of the right-hemisphere function in depression: solving the paradoxes. Prog Neuropsychopharmacol Biol Psychiatry 28:1–13.
   PubMed Web of Science ®Google Scholar
• Rotenberg VS. 2008. Functional brain asymmetry as a determinative factor in the treatment of depression: theoretical implications. Prog Neuropsychopharmacol Biol Psychiatry 32: 1772 1777.
   Google Scholar
• Rush AJ, Thase ME, Dube S. 2003. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 53: 743 753.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, . 2006. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New Engl J Med 354:1231–1242.
   PubMed Web of Science ®Google Scholar
• Rusjan PM, Barr MS, Farzan F, Arenovich T, Maller JJ, Fitzgerald PB, . 2010. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp 31:1643–1652.
   PubMed Web of Science ®Google Scholar
• Rybak M, Bruno R, Turnier L, Pridmore S. 2005. An attempt to increase the rate and magnitude of the antidepressant effect of transcranial magnetic stimulation (TMS). A Pilot Study. German J Psychiatry 8:59–65.
   Google Scholar
• Sackeim HA. 2001. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):10 17.
   PubMedGoogle Scholar
• Salustri C, Tecchio F, Zappasodi F, Bevacqua G, Fontana M, Ercolani M, . 2007. Cortical excitability and rest activity properties in patients with depression. J Psychiatry Neurosci 32:259–266.
   Google Scholar
• Schutter DJ. 2009. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 39:65–75.
   PubMed Web of Science ®Google Scholar
• Schweitzer I, Tuckwell V, Ames D, O'Brien J. 2001. Structural neuroimaging studies in late-life depression: a review. World J Biol Psychiatry 2:83–88.
   PubMedGoogle Scholar
• Speer AM, Kimbrell TA, Wassermann EM, J DR, Willis MW, Herscovitch P, . 2000. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 48:1133–1141.
   PubMed Web of Science ®Google Scholar
• Thase ME, Rush AJ. 1995. Treatment resistant depression. Bloom FE, Kupfer DJ. Psychopharmacology: the fourth generation of progress. New York: Raven Press Ltd. 1081–1097.
   Google Scholar
• Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, . 2006. Medication augmentation after the failure of SSRIs for depression. New Engl J Med 354:1243–1252.
   PubMed Web of Science ®Google Scholar
• Wassermann EM. 1998. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5 7, 1996. Electroencephalogr Clin Neurophysiol 108:1–16.
   PubMedGoogle Scholar